Assessment of maximum tolerated dose of a new herbal drig, Semelil (ANGIPARSTM) in patients with diabetic foot ulcer: A phase I clinical trial

Heshmat, R., K. Mohammad, M.R. Mohajeri Tehrani, O. Tabatabaie Malazy, A.A. Keshtkar, F. Gharibdoust and B. Larijani (2008) Assessment of maximum tolerated dose of a new herbal drig, Semelil (ANGIPARSTM) in patients with diabetic foot ulcer: A phase I clinical trial. [Publication]

Full text not available from this repository.
Item Type: Publication
Author(s): Heshmat, R., K. Mohammad, M.R. Mohajeri Tehrani, O. Tabatabaie Malazy, A.A. Keshtkar, F. Gharibdoust and B. Larijani
Author(s) order (without accents): Heshmat R K Mohammad MR Mohajeri Tehrani O Tabatabaie Malazy AA Keshtkar F Gharibdoust and B Larijani
Title order (without accents): Assessment of maximum tolerated dose of a new herbal drig Semelil (ANGIPARSTM) in patients with diabetic foot ulcer: A phase I clinical trial
Type of publication: Article / Letter to editor
Language: English
Published in: DARU 16, Suppl. 1, 25--30
Location: internet
Additional info: Semelil contains Melilotus officinalis Willd.
Checked: yes
ReferenceID: 177h
Date Deposited: 07 Jul 2017 12:32
Last Modified: 07 Jul 2017 12:32
URI: http://indianmedicine.eldoc.ub.rug.nl/id/eprint/49366

Actions (login required)

View Item View Item